Treatment to target in Type 2 diabetes: consistent risk reduction of hypoglycaemia with basal insulin glargine as compared with NPH insulin in insulin-naive patients on oral agents.

被引：0
|
作者：
Rosenstock, J
Riddle, M
机构：
[1] Med City Dallas, Dallas Diabet & Endocrine Ctr, Dallas, TX USA
[2] Oregon Hlth Sci Univ, Dept Med, Portland, OR 97201 USA
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
805
引用
收藏
页码：A259 / A259
页数：1
相关论文
共 50 条
  • [1] Treatment to target study:: Feasibility of achieving control with the addition of basal bedtime insulin glargine (Lantus®) or NPH insulin in insulin-naive patients with type 2 diabetes on oral agents
    Rosenstock, J
    Riddle, M
    Dailey, G
    Gerich, J
    Mecca, T
    Wilson, C
    Bugos, C
    [J]. DIABETES, 2001, 50 : A129 - A130
  • [2] Treatment to target study: Timing and frequency of nocturnal hypoglycemia. The value of adding bedtime basal insulin glargine over NPH insulin in insulin-naive patients with Type 2 diabetes on oral agents
    Rosenstock, J
    Riddle, MC
    [J]. DIABETES, 2002, 51 : A482 - A482
  • [3] Lower incidence of nocturnal hypoglycaemia in patients with Type 2 diabetes treated with insulin glargine compared with NPH insulin, given as a combination regimen with oral agents.
    Benedetti, MM
    Hamburg, E
    Dressler, A
    Ziemen, M
    [J]. DIABETOLOGIA, 2002, 45 : A259 - A259
  • [4] The Effectiveness of Basal Plus Compared with Premixed Insulin in Insulin-Naive Type 2 Diabetes Patients
    Raghavan, Arun
    Nanditha, Arun
    Satheesh, Krishnamoorthy
    Snehalatha, Chamukuttan
    Seeli, Abraham Catherin
    Simon, Mary
    Susairaj, Priscilla
    Ramachandran, Ambady
    [J]. DIABETES, 2019, 68
  • [5] Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy:: Comparison of insulin glargine with NPH insulin as basal insulin supplement
    Ploeckinger, Ursula
    Topuz, Mendaha
    Riese, Brigitte
    Reuter, Thomas
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 290 - 295
  • [6] Effect of insulin degludec on glycaemic control and nocturnal hypoglycaemia compared with insulin glargine: a 1-year trial in insulin-naive patients with type 2 diabetes
    Zinman, B.
    Philis-Tsimikas, A.
    Handelsman, Y.
    Rodbard, H. W.
    Cariou, B.
    Johansen, T.
    Endahl, L.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2012, 55 : S22 - S22
  • [7] Basal insulin peglispro versus insulin glargine in insulin-naive type 2 diabetes: IMAGINE 2 randomized trial
    Davies, M. J.
    Russell-Jones, D.
    Selam, J. -L.
    Bailey, T. S.
    Kerenyi, Z.
    Luo, J.
    Bue-Valleskey, J.
    Ivanyi, T.
    Hartman, M. L.
    Jacobson, J. G.
    Jacober, S. J.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1055 - 1064
  • [8] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
    Dailey, G. E.
    Gao, L.
    Aurand, L.
    Garg, S. K.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
  • [9] Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes
    Rodbard, H. W.
    Cariou, B.
    Zinman, B.
    Handelsman, Y.
    Wolden, M. L.
    Rana, A.
    Mathieu, C.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 869 - 872
  • [10] ADDING INSULIN GLARGINE TO ORAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES RESULTS IN LONGER PERSISTENCE WITH TREATMENT COMPARED TO NPH INSULIN
    Pfohl, M.
    Dippel, F. W.
    Kostev, K.
    Kotowa, W.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A509 - A510
12345